Cargando…
Validation of Novel Molecular Imaging Targets Identified by Functional Genomic mRNA Profiling to Detect Dysplasia in Barrett’s Esophagus
SIMPLE SUMMARY: Barrett’s esophagus (BE) is the precursor of esophageal adenocarcinoma (EAC). Dysplastic BE (DBE), including low-grade dysplasia (LGD) and high-grade dysplasia (HGD), shows a higher progression risk to EAC compared to non-dysplastic BE (NDBE). If LGD or HGD is detected, more intensiv...
Autores principales: | Zhao, Xiaojuan, Gabriëls, Ruben Y., Hooghiemstra, Wouter T. R., Koller, Marjory, Meersma, Gert Jan, Buist-Homan, Manon, Visser, Lydia, Robinson, Dominic J., Tenditnaya, Anna, Gorpas, Dimitris, Ntziachristos, Vasilis, Karrenbeld, Arend, Kats-Ugurlu, Gursah, Fehrmann, Rudolf S. N., Nagengast, Wouter B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139936/ https://www.ncbi.nlm.nih.gov/pubmed/35626066 http://dx.doi.org/10.3390/cancers14102462 |
Ejemplares similares
-
C-Met targeted fluorescence molecular endoscopy in Barrett's esophagus patients and identification of outcome parameters for phase-I studies
por: de Jongh, Steven J., et al.
Publicado: (2020) -
Standardization and implementation of fluorescence molecular endoscopy in the clinic
por: Sterkenburg, Andrea J., et al.
Publicado: (2022) -
CXCR4 peptide-based fluorescence endoscopy in a mouse model of Barrett’s esophagus
por: Marcazzan, Sabrina, et al.
Publicado: (2022) -
Adherence to pre-set benchmark quality criteria to qualify as expert
assessor of dysplasia in Barrett’s esophagus biopsies – towards digital review
of Barrett’s esophagus
por: van der Wel, MJ, et al.
Publicado: (2019) -
Identification and Validation of Esophageal Squamous Cell Carcinoma Targets for Fluorescence Molecular Endoscopy
por: Zhao, Xiaojuan, et al.
Publicado: (2021)